救济治疗法宣布了RLF-OD032的新研究结果,将临时专利存档。 Relief Therapeutics announces new study results for RLF-OD032, files provisional patents.

救济治疗机构公布了其药物RLF-OD032的新研究结果,并提交了与其调查结果有关的临时专利。 Relief Therapeutics announced new study results for its drug RLF-OD032 and has filed provisional patents related to its findings. 该公司旨在推进其研究,保护其在治疗空间的创新。 The company aims to advance its research and protect its innovations in the therapeutic space. 报告中没有详细说明该研究的结果和影响。 Further details on the study's outcomes and implications were not specified in the report.